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Abstract
Transient receptor potential canonical type 3 (TRPC3) channels are non-selective cation channels and regulate intracellular
Ca2+ concentration. We examined the role of TRPC3 channels in agonist-, membrane depolarization (high K+)-, and
mechanical (pressure)-induced vasoconstriction and vasorelaxation in mouse mesenteric arteries. Vasoconstriction and
vasorelaxation of endothelial cells intact mesenteric arteries were measured in TRPC3 wild-type (WT) and knockout (KO)
mice. Calcium concentration ([Ca2+]) was measured in isolated arteries from TRPC3 WT and KO mice as well as in the mouse
endothelial cell line bEnd.3. Nitric oxide (NO) production and nitrate/nitrite concentrations were also measured in TRPC3 WT
and KO mice. Phenylephrine-induced vasoconstriction was reduced in TRPC3 KO mice when compared to that of WT mice,
but neither high K+- nor pressure-induced vasoconstriction was altered in TRPC3 KO mice. Acetylcholine-induced
vasorelaxation was inhibited in TRPC3 KO mice and by the selective TRPC3 blocker pyrazole-3. Acetylcholine blocked the
phenylephrine-induced increase in Ca2+ ratio and then relaxation in TRPC3 WT mice but had little effect on those outcomes
in KO mice. Acetylcholine evoked a Ca2+ increase in endothelial cells, which was inhibited by pyrazole-3. Acetylcholine
induced increased NO release in TRPC3 WT mice, but not in KO mice. Acetylcholine also increased the nitrate/nitrite
concentration in TRPC3 WT mice, but not in KO mice. The present study directly demonstrated that the TRPC3 channel is
involved in agonist-induced vasoconstriction and plays important role in NO-mediated vasorelaxation of intact mesenteric
arteries.
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Introduction
Changes in intracellular calcium concentration ([Ca2+]i) lead to
diverse cellular responses, including vasoconstriction and release of
vasodilators such as nitric oxide (NO) from endothelial cells (ECs).
Vascular contractility is primarily mediated by [Ca2+]i increase in
response to agonists or mechanical stimulation [1]. The elevation
in [Ca2+]i results in activation of the Ca
2+/calmodulin-dependent
enzyme myosin light chain kinase and the subsequent phosphor-
ylation of regulatory myosin light chains (MLC20). This increased
MLC20 phosphorylation enhances actomyosin ATPase activity
and induces vascular contraction [2]. ECs also produce and
release vasoactive substances, such as nitric oxide (NO), to regulate
vascular contractility. It is well documented that Ca2+-dependent
mechanisms initiate the production and release of NO. The
elevation of [Ca2+]i in ECs activates nitric oxide synthase (NOS)
via the Ca2+/calmodulin complex, which catalyzes the production
of NO [3,4]. In non-excitable ECs, the increase in [Ca2+]i mainly
depends on Ca2+ influx through store-operated Ca2+ channels and
non-selective Ca2+ channels [5].
Transient receptor potential (TRP) channels are non-selective
cation channels [6] that directly act as Ca2+ entry channels in the
plasma membrane or change membrane potentials, thereby
modulating the driving forces for Ca2+ entry, to regulate [Ca2+]i
[7,8]. In mammals, almost 30 members of the TRP family have
been discovered [9,10]. Among the subfamilies of TRP channels,
canonical TRPs (TRPCs), including TRPC3, are expressed in
smooth muscle and endothelial cells [11–16]. TRPC3 functions as
both a receptor-operated Ca2+entry channel and a store-operated
channel [6,13,17–19]. Therefore, TRPC3 channels may play an
important role in agonist-induced contraction and production of
NO.
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Several studies have described the role of TRPC3 channels in
vascular contractility. It was shown that antisense suppression of
TRPC3 significantly attenuated UTP-induced membrane depo-
larization and constriction [13]. It was also reported that TRPC3
channels are upregulated in TRPC6-deficient smooth muscle cells,
and increased TRPC3 enhanced systemic blood pressure and
agonist-induced contraction in intact cerebral arteries [20].
Additionally, high levels of TRPC3 protein are expressed in
spontaneously hypertensive rats (SHR), as well as in patients with
hypertension, and upregulated TRPC3 increased the Ca2+ influx
in SHRs compared with normotensive Wistar-Kyoto rats (WKY)
[21–24]. The accumulated evidence suggests that TRPC3
channels may play an important role in agonist-induced contrac-
tion and cardiovascular disease, especially hypertension. On the
other hand, TRPC3 channels are recognized as important Ca2+-
permeable cation channels in NO production. TRPC3 involve-
ment has been shown in flow- and bradykinin-induced vasodila-
tion in rat small mesenteric arteries, probably by mediating the
Ca2+ influx into ECs [12,25]. TRPC3 was also shown to
participate in EC Ca2+ influx and vasorelaxation of the aorta [26].
Despite several years of study regarding the possible role of
TRPC channels as store-operated Ca2+ channels and receptor-
operated Ca2+ channels, surprisingly little information exists
regarding their role in the mechanisms of vasoconstriction and
vasorelaxation in intact arteries. Because selective pharmacological
inhibitors for TRPC3 are not available, the use of gene knockout
(KO) mice offers a good option for studying specific roles of TRPC
in vascular contractility regulation. In the present study, we
investigated the role of the TRPC3 channel in the agonist
(phenylephrine)-, mechanical (pressure)-, and membrane depolar-
ization (high K+)-induced vasoconstriction of mouse ECs intact
mesenteric arteries from TRPC3 KO mice. We also determined
the functional role of TRPC3 in endothelium-dependent vasore-
laxation. We show here that the TRPC3 channel is involved in
agonist-induced vasoconstriction and critically functions in NO-
mediated vasorelaxation of ECs intact mesenteric arteries.
Materials and Methods
This investigation conforms to the Guide for the Care and Use of
Laboratory Animals, published by the US National Institutes of
Health (NIH publication No. 85–23, revised 1996). The experi-
mental protocols used in this study were reviewed and approved
by the Ethic Committee, Institutional Animal Care and Use
Committee of Yonsei University Health System.
Animal model
Generation of TRPC3 KO mice has been described previously
[27]. TRPC KO mice were provided by Dr. JY Kim. TRPC3
littermates were analyzed by PCR, using the genomic DNA
extracted from the tails of mice as templates and the forward and
reverse primer pair. Primer sequences were as follows:
mrTRPC3.s, 59-ATT CTT CGA AGC CCC TTC AT-39;
mrTRPC3.as, 59-CTC CTT GCA CTC AGA CCA CA-39.
Tissues preparation and EC bENd.3 cells
Six to eight week-old TRPC3 KO and age-matched WT mice,
as controls, were euthanized using CO2 gas. The depth of
anaesthesia was evaluated by pinching the animal’s paw with
forceps. The mesenteric arteries were removed and immersed in
normal Krebs-Henseleit (KH) solution composed of (in mmol/L):
NaCl (119), CaCl2(2.5), NaHCO3(25), MgSO4(1.2), KH2O4(1.2),
KCl (4.6), and glucose (11.1). The KH solution was continuously
aerated with a 95% O2 and 5% CO2 gas mixture. Second-order
mesenteric arteries (2,3 mm long) were carefully dissected from
surrounding adipose tissue under a dissecting microscope (Nikon,
Tokyo, Japan).
Mouse endothelial cell bEnd.3 cells were used in endothelial
[Ca2+]i measurement experiments. The bEnd.3 cell line (American
Type Culture Collection, Manassas, VA, USA) is an immortalized
mouse cell line from brain capillary endothelial cells. Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM; Gibco
Invitrogen, Carlsbad, CA, USA) containing high glucose concen-
tration (4.5 g/L) and 10% fetal bovine serum (FBS; Gibco
Invitrogen). Cells were cultured in a humidified cell culture
incubator at 37uC and an atmosphere of 5% CO2/95% air. The
bEnd.3 cells used in this study were passaged between 12 to 20
times.
Arteriograph-derived diameter measurement, as an
indicator of vasoconstriction, vasorelaxation, and
pressure-induced myogenic tone
The diameter measurement methods using an arteriograph
system were described in a previous study [28,29]. Mesenteric
artery segments (100–180 mm inner diameter and 2–3 mm in
length) were dissected and cannulated in a pressure myograph
(Living Systems Instrumentation, Burlington, VT, USA), filled
with KH solution, and subsequently placed on the stage of an
inverted microscope (Eclipse TS100/TS100-F, Nikon Inc.,
Melville, NY, USA). The proximal cannula was connected to a
solid-state pressure transducer and a reservoir of KH solution, and
the intraluminal pressure was controlled by a pressure servo-
controller to adjust the transmural pressures. The distal cannula
was connected to the luer-lock valve, which was opened to flush
the lumen during the initial cannulation. After cannulation, the
valve was closed, and all measurements were conducted under no-
flow conditions. The arterial lumen diameter was recorded using
the Soft Edge Acquisition Subsystem (IonOptix, Milton, MA,
USA).
The KH perfusion and superfusion of the arterial segments was
equilibrated with a 95% O2 and 5% CO2 gas mixture at 37uC.
After mounting, the mesenteric arterial segments were stretched
longitudinally to the approximate in situ length and were
maintained at a 40 mmHg transmural pressure for a 40–60 min
equilibration period.
In the present study, ECs intact arteries were used in all
experiments. Endothelial function was checked at the beginning of
each experiment with 1 mM acetylcholine in arteries that were
precontracted using 70 mM K+ solution (equimolar substitution of
Na+ with K+).
After equilibration, to compare vasoconstriction between TRPC
KO and WT mice, the cumulative concentration-response curves
of phenylephrine (10 nmol/L to 10 mmol/L) and 70 mM K+
solution-induced vasoconstriction were measured in vessels of
TRPC3 KO and age-matched WT mice.
To compare vasorelaxation between TRPC KO and WT mice,
the cumulative concentration-response curves of acetylcholine
(10 nmol/L to 100 mmol/L) were evaluated in arteries precon-
tracted with phenylephrine (10 mmol/L). For sodium nitroprus-
side, we examined the effect of a single concentration (10 mmol/
L). We also examined the effect of pyrazole-3 (ethyl-1-(4-(2,3,3-
trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-
carboxylte, 3 mmol/L), a selective TRPC3 blocker, on acetylcho-
line-induced vasorelaxation in TRPC WT mice.
In vasoconstriction and vasorelaxation experiments, artery
diameter changes are expressed as a percentage of the maximal
dilation achieved by replacing the control KH solution with Ca2+-
free KH solution at the end of the experiment.
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Pressure-induced myogenic tone was measured in mesenteric
arteries of TRPC KO and WT mice as previously described [28].
After being mounted and equilibrated at a 40 mmHg intraluminal
pressure, the pressure was increased in a stepwise manner from 20
to 140 mmHg in 20 mmHg increments, and each pressure was
maintained for 10 min to allow the blood vessel diameter to
stabilize before measurement. After a series of step changes, the
transmural pressure was returned to 40 mmHg, and the vessel was
allowed to re-equilibrate for minimum of 40 min. At the end of
each experiment, a passive pressure-diameter relationship was
established in Ca2+-free KH solution containing 0.1 mmol/L
nifedipine to determine the maximum passive diameter. Myogenic
tone was calculated s a percent decrease in diameter from fully
relaxed diameter in Ca2+-free KH solution with nifedipine by the
equation: [12(DA/DP)]6100%, where DA is the active diameter
at a given pressure in normal KH solution in the presence of
extracellular Ca2+ and DP is the passive diameter at a given
pressure in Ca2+-free KH solution with 0.1 mmol/L nifedipine.
Simultaneous measurement of [Ca2+]i and diameter in
pressurized arteries
Changes in [Ca2+]i and diameter in the pressurized arteries of
TRPC KO and WT mice were measured as previously described
[28]. Mesenteric artery segments were loaded with the Ca2+-
sensitive fluorescent indicator Fura-2AM (10 mmol/L; Molecular
Probes, Eugene, OR, USA) and 0.02% Cremophor EL (Sigma, St
Lois, MO, USA) in KH as previously reported [30]. Arteries were
incubated in this solution for 3 h at room temperature in the dark.
Fura-2AM-loaded mesenteric artery segments were mounted in a
pressure myograph, pressurized to 40 mmHg using a pressure
servo-controller, and then superfused with KH (37uC) that was
aerated with 95% O2 and 5% CO2 to wash out excess dye and
allow for hydrolysis of acetoxymethyl ester (AM) groups by
intracellular esterases. Fura-2AM-loaded vessels were alternately
excited at 340 and 380 nm at a frequency of 1 Hz with an
IonOptix Hyperswitch dual excitation light source, and the
respective 510 nm emissions were detected with a photomultiplier
tube. Background-subtracted 340/380 emission ratios (R340/380)
were calculated with IonOptix Ion Wizard software and recorded
continuously throughout the experiment. The fluorescence emis-
sion at 510 nm (R340/380) and the changes in arterial diameter,
monitored by videomicroscopy (IonOptix), were recorded simul-
taneously.
In the present study, changes in smooth muscle [Ca2+]i and
diameter upon application of acetylcholine (10 mmol/L) was
recorded simultaneously in precontracted arteries of TRPC KO
and WT mice treated with phenylephrine (10 mmol/L).
Measurement of [Ca2+]i ratio in bEnd.3 cells
The [Ca2+]i increase in response to acetylcholine treatment
(10 mmol/L) was measured in mouse endothelial bEnd.3 cells in
the absence and presence of pyrazole-3 (3 mmol/L) using
ratiometric imaging system (Nippon Roper, Tokyo, Japan).
Cells were placed on coverslips in 24-well plates and loaded with
5 mmol/L Fura-2AM for 20 min at 37uC in serum free medium.
After incubation, the coverslips were placed into dishes and
perfused with PSS. The endothelial Ca2+ ratio was determined by
measuring the fluorescence of Fura-2AM at excitation of 340 and
380 nm, and the emission at 510 nm was simultaneously
monitored using the Ratiometric Imaging System (Model Cascade
512B Set, Nippon Roper).
Detection of NO fluorescence using 4,5-
diaminofluorescence-2 diacetate
NO production in mesenteric arteries was measured using
DAF-2 DA (Santa Cruz Biotech, Dallas, TX, USA), a specific NO
indicator. After equilibration for 30–40 min, DAF-2DA (1 mmol/
L) and acetylcholine (1025 mol/L) were added to each artery for
30 min at 37uC in KH solution, and the arteries were then washed
with KH solution. Fluorescent images at 480 nm excitation were
detected on a fluorescent inverted microscope (IX71/DP71,
Tokyo, Japan). All images were acquired and analyzed using the
Metamorph software (Molecular Devices, Sunnyvale, CA, USA).
Determination of nitrate/nitrite concentration using a
colorimetric assay kit
The concentrations of nitrate/nitrite (NO metabolites) were
determined using a commercially available colorimetric assay
(Sigma) according to the manufacturer’s instructions. Briefly,
isolated mesenteric arteries were stimulated with acetylcholine
(10 mmol/L) for 24 h. To measure nitrate/nitrite concentrations,
conditioned medium was collected and incubated at room
temperature with nitrate reductase and enzyme cofactor, and
Griess reagent A and B were added in consecutive order. The
absorbance of the mixture at 540 nm was determined with a
microplate reader (VERSAmax, Molecular devices, Union City,
USA).
Hematoxylin and Eosin staining
Mesenteric arteries of TRPC3 WT and KO mice were carefully
isolated and then fixed with 4% paraformaldehyde for 1 h.
Samples were embedded in OCT compound and 10-mm-thick
sections were cut for hematoxylin and eosin staining. The slides
were examined using a light microscope (BX51/BX61, Olympus,
Tokyo, Japan).
Statistics
All values given in the text are expressed as mean6SEM and
were analyzed by two-way ANOVA, followed by the Student-
Newman-Keuls post hoc test. Differences were considered
significant if P,0.05.
Results
Role of TRPC3 in vasoconstriction
To study if TRPC3 channels affect vasoconstriction, we
compared vascular responsiveness to agonist (phenylephrine)-,
membrane depolarization (high K+)-, and mechanical (pressure)-
induced vasoconstriction between ECs intact mesenteric arteries of
TRPC3 WT and KO mice. We first examined the effect of
TRPC3 on phenylephrine-induced vasoconstriction in mesenteric
arteries from TRPC3 WT and KO mice. As shown in Fig. 1A,
phenylephrine induced concentration-dependent vasoconstriction.
Phenylephrine-induced vasoconstriction was decreased in TRPC3
KO mice compared to TRPC3 WT mice. The magnitude of the
10 mmol/L phenylephrine-induced vasoconstriction in TRPC3
WT and KO mice was 90.662.3% and 75.464.6% (n= 8–9),
respectively. In response to 70 mmol/L KCl-induced vasocon-
striction, there was no difference between TRPC3 WT and KO
mice (Fig. 1B, n= 12–14).
To evaluate the role of TRPC3 in myogenic tone, we evaluated
pressure-induced myogenic tone in ECs intact mesenteric arteries
of TRPC3 WT and KO mice. When intraluminal pressure was
increased in a stepwise manner from 20 to 140 mmHg in 20-
mmHg increments, mesenteric arteries constricted in response to
TRPC3 Channels Control the Vascular Contractility
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an increase in intraluminal pressure similarly between TRPC3
WT and KO mice (Fig. 1C, n= 6–8).
Role of TRPC3 in vasorelaxation
We compared endothelium dependent- and independent-
vasorelaxation between TRPC3 WT and KO mice. To determine
the role of TRPC3 in endothelium-dependent relaxation, we
compared acetylcholine-induced relaxation in phenylephrine
precontracted ECs intact arteries from TRPC3 WT and KO
mice (Fig. 2A). Acetylcholine produced concentration-dependent
vasorelaxation that was significantly reduced in TRPC3 KO mice
compared to WT mice (n = 11). We additionally examined the
contribution of TRPC3 to the endothelium-dependent relaxation
using the selective TRPC3 blocker pyrazole-3. Treatment with
3 mmol/L pyrazole-3 resulted in significant inhibition of the
acetylcholine-induced vasorelaxation in the mesenteric arteries of
TRPC3 WT mice (n = 7).
To examine endothelium-independent relaxation, we also
compared sodium nitroprusside-induced relaxation in phenyleph-
rine precontracted ECs intact arteries from TRPC3 WT and KO
mice (Fig. 2B). However, there was no significant difference
between TRPC3 WT and KO mice. The mean vasorelaxation
induced by 10 mmol/L sodium nitroprusside was 97.060.5% and
94.061.7% (n= 4–6) for TRPC3 WT and KO mice, respectively.
Because Ca2+ plays a critical role in the regulation of vascular
tone, we compared the effect of acetylcholine on phenylephrine-
induced changes in Ca2+ ratio and vessel diameter between ECs
intact mesenteric arteries of TRPC3 WT and KO mice. As shown
in Fig. 3, the addition of 10 mmol/L acetylcholine inhibited the
phenylephrine-induced increase in Ca2+ ratio and subsequent
relaxation of phenylephrine-constricted arteries in TRPC3 WT
mice. However, acetylcholine had little effect on the increase in
Ca2+ ratio and vasoconstriction evoked by stimulation with
10 mmol/L phenylephrine in TRPC3 KO mice. We also
compared the 10 mmol/L phenylephrine-induced Ca2+ ratio
between WT and TRPC3 KO mice. Phenylephrine-induced
Ca2+ ratio was significantly decreased in TRPC3 KO mice
compared to TRPC3 WT mice. In the TRPC3 WT mice, the
amplitude of the phenylephrine-induced Ca2+ ratio was
93.468.2% (n= 6) in the absence of acetylcholine and
12.666.2% (n= 6) in the presence of acetylcholine. However, in
the TRPC3 KO mice, the amplitude of the phenylephrine-
induced Ca2+ ratio was 64.266.0% (n= 5) in the absence of
acetylcholine and 43.964.9% (n= 5) in the presence of acetyl-
choline.
Role of TRPC3 in the [Ca2+]i response to acetylcholine in
bEnd.3 mouse endothelial cells
We evaluated the specific role of endothelial cell TRPC3 in the
acetylcholine-induced increase in [Ca2+]i using bEnd.3 mouse
endothelial cells. As shown in Fig. 4, the application of 10 mmol/L
acetylcholine to endothelial cells caused a significant, rapid rise in
Figure 1. The effect of TRPC3 KO on vasoconstriction of ECs intact mesenteric arteries. A1. Representative recordings of the differences in
phenylephrine-induced vasoconstriction between WT and TRPC3 KO mice. A2. Mean data for phenylephrine-induced vasoconstriction in WT and
TRPC3 KO mice (n = 8–9). B. Mean data for 70 mmol/L KCl-induced vasoconstriction in WT and TRPC3 KO mice (n = 12–14). Vessel diameter was
measured at an intraluminal pressure of 40 mmHg, C1. Representative recordings of the differencesin pressure-induced myogenic tone between WT
and TRPC3 KO mice. C2. Mean data for pressure-induced myogenic tone in WT and TRPC3 KO mice (n = 6–8). Data are expressed as mean6 SEM. *P,
0.05. ILP: intraluminal pressure.
doi:10.1371/journal.pone.0110413.g001
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[Ca2+]i, followed by a secondary sustained [Ca
2+]i plateau
(Fig. 4A). Exposure of endothelial cells in the resting state to
3 mmol/L pyrazole-3 did not change the resting level of [Ca2+]i.
However, the acetylcholine-induced rapid increase in [Ca2+]i and
secondary sustained plateau were significantly inhibited by pre-
incubation With pyrazole-3. In a control experiment, we measured
differences in [Ca2+]i with two consecutive challenges of acetyl-
choline. There was little difference in the magnitude o the Ca2+
response with two consecutive challenges with acetylcholine
(Fig. 4B).
We also determined the function of TRPC3 as a store-operated
Ca2+ entry (SOCE) channel using store-depleting sarco2/
endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor thapsi-
gargin. The Fura-2-fluorescence ratio prior to extracellular Ca2+
removal was similar in the absence and presence of 3 mmol/L
pyrazole-3 of bEnd.3 mouse endothelial cells (Fig. 4C). Addition of
the thapsigargin (1 mmol/L) triggered release of Ca2+ from
intracellular stores, leading to rapid, transient increase in cytosolic
Ca2+. As illustrated in Fig. 4C, the subsequent addition of
extracellular Ca2+ was followed by a rapid increase of Fura-2-
fluorescence in both cell types reflecting SOCE. In the presence of
pyrazole-3, the peak of SOCE was partially reduced, but not
significantly and the slope of SOCE was similar in the absence and
presence of pyrazole-3.
Role of TRPC3 in NO production
To determine if the decrease in vasorelaxation in TRPC3 KO
mice was caused by decreased NO production, we measured NO
production using DAF-2DA, a nitric oxide-specific fluorescent
indicator (Fig. 5). Acetylcholine elicited NO production from the
endothelium of TRPC3 WT controls, with DAF-2 DA fluores-
cence intensity increasing by 18-fold in the arteries treated with
acetylcholine compared to untreated arteries. However, in
TRPC3 KO mice, acetylcholine had little effect on DAF-2 DA
fluorescence intensity. We also measured nitrate/nitrite concen-
tration as an indicator of NO production. When acetylcholine was
added to arteries from TRPC3 WT mice, nitrate/nitrite
concentration was increased to 2.861.1 mmol/L (n= 4) from the
untreated level of 0.460.2 mmol/L (n = 4). However, there was no
change in nitrate/nitrite concentration in response to acetylcho-
line in arteries for TRPC3 KO mice.
Discussion
In the present study, we determined the role of TRPC3
channels in vascular contractility using TRPC3 KO mice and
demonstrated two major findings. First, TRPC3 channels may
play an important role in agonist-induced contraction. We
demonstrated that phenylephrine-induced vasoconstriction is
Figure 2. The effect of TRPC3 KO on vasorelaxation of ECs intact mesenteric arteries. A1. Representative recordings of vasorelaxation in
response to acetylcholine in WT and KO mice. A2. Mean data for vasorelaxation in response to acetylcholine in WT and TRPC3 KO mice, and the effect
of pyrazole- 3 on acetylcholine-induced vasorelaxation in WT mice. Pyrazole-3 was administered 30 min before application of phenylephrine (PE). B1.
Representative recordings of vasorelaxation in response to sodium nitroprusside in WT and KO mice. B2. Mean data for vasorelaxation in response to
sodium nitroprusside in WT and TRPC3 KO mice. Data are expressed as mean 6 SEM (n = 4–6) and are normalized to the maximal vasoconstriction to
phenylephrine (10 mmol/L). *P,0.005 and #P,0.05, compared to WT mice.
doi:10.1371/journal.pone.0110413.g002
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decreased in TRPC3 KO mice when compared to that of WT
mice, but neither membrane depolarization (high K+)- nor
mechanical (pressure)-induced vasoconstriction were altered in
TRPC3 KO mice. Secondly, endothelial TRPC3 contributes to
endothelial NO release and subsequent endothelium-dependent
vasorelaxation, which was evidenced as follows: (1) acetylcholine-
induced vasorelaxation was inhibited in TRPC3 KO mice and by
the selective TRPC3 blocker, pyrazole-3; (2) acetylcholine
inhibited the phenylephrine-induced increase in [Ca2+]i ratio
and subsequent relaxation in vessels from TRPC3 WT mice, but
had little effect on those parameters in KO mice; (3) acetylcholine
induced increases in [Ca2+]i in endothelial cells, which was
inhibited by pyrazaole-3; (4) NO was released from mesenteric
artery segments from WT mice in response to acetylcholine, but
not from vessels from KO mice.
Role of TRPC3 in vasoconstriction
TRPC channels are Ca2+-permeable non-selective cation
channels in vascular cells [6]. Physiologically, Ca2+ influx through
TRPCs leads to an [Ca2+]i elevation that drives vascular smooth
muscle cell contraction, leading to vasoconstriction of resistance
arteries and thus, elevated peripheral resistance and blood
pressure [20,31]. In the present study, we investigated the role
of TRPC3 in vasoconstriction of resistance arteries, such as the
mesenteric arteries, under in response to agonist (phenylephrine),
membrane depolarization (high K+), and mechanical (pressure)
changes. In phenylephrine-induced vasoconstriction, we demon-
strated phenylephrine-induced vasoconstriction is inhibited in
TRPC3 KO mice when compared to that of WT mice. We also
demonstrated phenylephrine-induced Ca2+ ratio was significantly
decreased in TRPC3 KO mice compared to TRPC3 WT mice.
These results suggest that TRPC3 plays an important role in
receptor-mediated contractile mechanisms [13,32,33]. However,
membrane depolarization-induced vasoconstriction, using high K+
concentrations, was not inhibited in TRPC3 KO mice. We also
investigated the role of TRPC3 in pressure-induced myogenic tone
and demonstrated that there was no significant difference between
TRPC3 WT and KO mice. Our results suggest that TRPC3 is not
important for membrane depolarization-induced contraction and
involved in pressure-induced myogenic tone. Recently identified
mammalian TRP channels are candidates for mechanosensory
functions in arterial smooth muscle [34,35]. Two members of the
TRP family, TRPC6 and TRPM4, are considered mediators of
pressure-induced myogenic constriction in cerebral vessels [36,37].
Although there are many previous reports about the role of
TRPC3 in agonist-induced vasoconstriction, no previous reports
have elucidated the role of TRPC3 channels in other methods of
vasoconstriction. Therefore, our results provide more extensive
experimental evidence for the role of TRPC3 channels in
vasoconstriction.
Role of TRPC3 in endothelium-dependent vasorelaxation
Because TRPC channels may be store-operated Ca2+ channels
as well as receptor-operated Ca2+ channels, these channels are
believed to promote vasorelaxation through increased endothelial
Ca2+ and subsequent activation of NO. In fact, it was reported
Figure 3. Changes in the [Ca2+]i and the vessel diameter induced by acetylcholine treatment in phenylephrine precontracted ECs
intact mesenteric arteries from WT and TRPC3 KO mice. A. Representative recordings of changes in the [Ca2+]i, expressed as the ratio of
510 nm emission fluorescence evoked by 340 and 380 nm excitation light (380/340 [Ca2+]i ratio) and the diameter in response to acetylcholine in
phenylephrine precontracted arteries. B. Statistical analysis of changes in the [Ca2+]i ratio induced by acetylcholine treatment between WT and TRPC3
KO mice. Data are expressed as mean 6 SEM (n= 5–6) and relative percentage of the 70 mmol/L KCl-induced [Ca2+]i ratio. *P,0.05.
doi:10.1371/journal.pone.0110413.g003
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that TRPC channels are expressed in endothelial cells and
contribute to endothelial cell Ca2+ regulation [38,39]. It was also
reported that TRPC3 participate in endothelial cell Ca2+ influx
and vasorelaxation of the aorta [26]. This evidence suggests that
TRPC3 channels may function in endothelium-dependent vaso-
relaxation. It is well known that conduit arteries, such as the aorta,
contribute to an increase in systolic blood pressure and pulse wave
velocity [40], and increased vasoconstriction of conduit arteries
contributes to the production and/or maintenance of hyperten-
sion. However, resistance arteries, such as the mesenteric arteries,
also play important roles in hypertension, especially in relation to
increased peripheral resistance. Therefore, the role of TRPC3 in
vasoconstriction and vasorelaxation in resistance arteries needs to
be determined. In experiments performed with resistance arteries,
TRPC3 was shown to be involved in flow- and bradykinin-
induced vasodilation in rat small mesenteric arteries, probably by
mediating the Ca2+ influx into endothelial cells [12,25]. However,
the previous findings measured only the effect of TRPC3 antisense
oligonucleotides on the bradykinin-induced vasorelaxation and
endothelial [Ca2+]i. Senadheera et al (2012) reported that the
importance of TRPC3 in endothelium-dependent vasorelaxation
due to endothelium-derived hyperpolarization (EDH) in mesen-
teric artery using TRPC3 KO mice [41]. Senadheera et al (2012)
pointed the Ca2+ influx via TRPC3 of endothelial cells plays
important role in EDH through KCa (Ca
2+-activated K+ channel)
activation. Although Senadheera et al (2012) pointed the role of
Ca2+ influx via TRPC3 in endothelium-dependent vasorelaxation,
further studies were required to determine the role of TRPC3 in
NO production and NO-dependent vasorelaxation. In order to
provide conclusive experimental evidence that TRPC3 channels
function in endothelium-dependent vasorelaxation, in the present
study, we examined the following: (1) the comparison of
acetylcholine-induced vasorelaxation between TRPC3 WT and
KO mice, (2) the effect of the selective TRPC3 blocker pyrazole-3
on acetylcholine-induced vasorelaxation in TRPC3 WT mice, (3)
the comparison of the acetylcholine effect on the phenylephrine-
induced increase in [Ca2+]i ratio and vasoconstriction between
TRPC3 WT and KO mice, (4) the changes in endothelial [Ca2+]i
Figure 4. The effect of the TRPC3 channel blocker pyrazole-3 on the acetylcholine-induced [Ca2+]i increase and store-operated Ca
2+
entry in bEnd3 mouse endothelial cells. A1 and A2. Representative recordings (A1) and mean data (A2) of the effect of pyrazole-3 on the
acetylcholine-induced increase in [Ca2+]i. 3 mmol/L pyrazole-3 was added 30 min before the application of 10 mmol/L acetylcholine. B1 and B2.
Differences in [Ca2+]i between two consecutive challenges of acetylcholine. Data are expressed as mean6 SEM (n= 17–23). *P,0.05. C1 and C2. Store
operated Ca2+ entry in the absence and presence of pyrazole-3 of bEnd3 mouse endothelial cells. C1. Representative recordings of Ca2+ ratio in
fluorescence spectrometry before, during and after Ca2+ depletion with subsequent addition of thapsigargin (1 mmol/L) in the absence and presence
of purazole-3. C2. mean data (n = 19) of peak increase of Ca2+ ratio following readdition of extracellular Ca2+ in the absence and presence of pyrazole-
3.
doi:10.1371/journal.pone.0110413.g004
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in response to treatment with acetylcholine and pyrazole-3 and (5)
the comparison of acetylcholine-induced NO release and nitrate/
nitrite concentration between TRPC3 WT and KO mice.
In the present study, we demonstrated that acetylcholine-
induced vasorelaxation is inhibited in TRPC3 KO mice and by
pyrazole-3. We also demonstrated that acetylcholine inhibited the
phenylephrine-induced increase in [Ca2+]i ratio and subsequent
relaxation in TRPC3 WT mice, but had little effect on
phenylephrine-induced increase in [Ca2+]i ratio and vasoconstric-
tion in KO mice. These results suggest that TRPC3 contributes to
the endothelium-dependent vasorelaxation, consistent with previ-
ous findings [12,25]. It was well known that endothelium-
dependent vasorelaxation is mediated by an increase in endothelial
Ca2+ concentration, with subsequent production of NO [3,4]. To
further confirm the role of TRPC3 in endothelium-dependent
vasorelaxation, we measured the changes in endothelial [Ca2+]i
and NO concentration in response to acetylcholine. We demon-
strated that acetylcholine treatment increased [Ca2+]i in bEnd.3
mouse endothelial cells, and this increase in [Ca2+]i was inhibited
by pyrazole-3. We also demonstrated that NO production in
response to acetylcholine was increased in TRPC3 WT mice, but
not in KO mice. Acetylcholine also increased the nitrate/nitrite
production by mesenteric arteries of WT mice, but not of TRPC3
KO mice.
In the present study, we did not demonstrate the localization of
TRPC3 in ECs. However, Senadheera et al (2012) [41] showed
the loss of TRPC3 in ECs of TRPC3 KO mice generated by same
protocol with the present study. They demonstrated the presence
of TRPC3 in aortic endothelium and smooth muscle using
TRPC3 antibody confocal immunohistochemistry. They also
demonstrated TRPC3 was absent in both cell layers of vessels
from TRPC3 KO mouse. Therefore, the inhibition of endothe-
lium-dependent vasorelaxation in TRPC3 KO mice may be due
to decrease in Ca2+ influx via TRPC3 channels of ECs. These
results suggest that TRPC3 participates in endothelial cell Ca2+
influx and NO production.
Ca2+ influx through plasma membrane Ca2+-permeable chan-
nels plays an important role in endothelial cell physiology and
changes in intracellular Ca2+ concentration associated to receptor-
operated Ca2+ entry have a profound impact on diverse
endothelial function [42]. TRPC channels are now recognized
among the most important Ca2+-permeable channels in vascular
endothelium and the endothelium TRPC3-mediated Ca2+ influx
may contributes to release of NO [12]. However, TRPC3 is
activated downstream phosphoinositide-specific phospholipase C
and can mediate SOCE and non-SOCE (second messenger-
operated Ca2+ channels and receptor-operated Ca2+ channels)
under physiological conditions of receptor stimulation by acetyl-
choline [42]. In the present study, therefore, it is unclear which
mechanism between SOCE and non-SOCE involve in NO
production via endothelium TRPC3-mediated Ca2+ influx.
Pyrazole-3 may can inhibits receptor-operated Ca2+ channels as
well as SOCE channels [43]. To determine if the SOCE
mechanism involved in TRPC3-mediated Ca2+ influx, in the
present study, we tested the effect of pyrazole-3 on SOCE using
SERCA inhibitor thapsigargin. Although the peak of SOCE was
partially reduced, but not significantly, in the presence of pyrazole-
3 and the slope of SOCE were similar in the absence and presence
of pyrazole-3. Therefore, TRPC3 may plays role in NO-mediated
vasorelaxation as a receptor mediated Ca2+ channels in endothe-
lial cells. However, the function of TRPC3 as part of SOCE
channels was not fully ruled out and remains to be elucidated.
Figure 5. NO production by ECs intact mesenteric artery fragments fromWT and TRPC3 KOmice. A. The effect of acetylcholine on DAF-2
DA fluorescence intensity in mesenteric arteries from WT and KO mice. B. The effect of acetylcholine on nitrate/nitrite concentration in arteries from
WT and KO mice (n = 4). *P,0.05.
doi:10.1371/journal.pone.0110413.g005
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In summary, the present study directly demonstrated that the
TRPC3 channel functions in agonist-induced vasoconstriction and
plays a major role in NO-mediated vasorelaxation of intact
mesenteric arteries.
Author Contributions
Conceived and designed the experiments: YHL JYK. Performed the
experiments: SIY DSY. Analyzed the data: YHL SIY JYK. Contributed
reagents/materials/analysis tools: JA LB SM. Contributed to the writing of
the manuscript: YHL SIY LB SM.
References
1. Matchkov VV, Kudryvtseva O, Aalkjaer C (2011) Intracelluar Ca2+ signaling
and phenotype of vascular smooth muscle cells. Basic Clin Pharmacol Toxicol
110: 42–48.
2. Cartwright EJ, Oceandy D, Austin C, Neyses L (2011) Ca2+ signaling in
cardiovascular disease: the role of the plasma membrane calcium pumps. Sci
China Life Sci 54(8): 691–698.
3. Forstermann U, Sessa WC (2012) Nirtric oxide synthases: regulation and
function. Eur Heart J 33: 829–837.
4. Schneider JC, El Kebir DE, Chereau C, Lanone S, Huang XL, et al. (2003)
Involvement of Ca2+/calmodulin-dependent protein kinase II in endothelial NO
production and endothelium-dependent relaxation. Am J Physiol 284: H2311–
H2319.
5. Nilius B, Droogmans G (2001) Ion channels and their role in vascular
endothelium. Physiol Rev 81: 1415–1459.
6. Birnbaumer L (2009) The TRPC class of ion channels: a critical review of their
roles in slow, sustained increases in intracellular Ca2+ concentrations. Annu Rev
Pharmacol Toxicol 49: 395–426.
7. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, et al. (2002) A
unified nomenclature for the superfamily of TRP cation channels. Mol Cell 9:
229–231.
8. Watanabe H, Murakami M, Ohba T, Takahashi Y, Ito H (2008) TRP channel
and cardiovascular disease. Pharmacol Ther 118: 337–351.
9. Gaudet R (2008) TRP channels entering the structural era. J Physiol 586(13):
3565–3575.
10. Gees M, Colsoul B, Nilius B (2010) The role of transient receptor potential
cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol 2(10):
a003962.
11. Beech DJ (2013) Characteristics or transient receptor potential canonical
calcium-permeable channels and their relevance to vascular physiology and
disease. Circ J 77(3): 570–579.
12. Huang JH, He GW, Xue HM, Yao XQ, Liu XC, et al. (2011) TRPC3 channels
contributes to nitric oxide release: siginificance during normoxia and hypoxia-
reoxygenation. Cardiovasc Res 91: 472–482.
13. Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE (2005) TRPC3
mediates pyrimidine receptor-induced depolarization of cerebral arteries.
Am J Physiol 288: H2055–H2061.
14. Wong CO, Yao X (2011) TRPC channels in vascular endothelial cells. Transient
receptor potential channels. Adv Exp Med Biol 704: 759–780.
15. Yao X, Garland CJ (2005) Recent developments in vascular endothelial cell
transient receptor potential channels. Circ Res 97: 853–863.
16. Yip H, Chan WY, Leung PC, Kwan HY, Liu C, et al. (2004) Expression of
TRPC homologs in endothelial cells and smooth muscle layers of human
arteries. Histochem Cell Biol 122: 553–561.
17. Gao G, Bai XY, Liu XC, Jing WB, Novakovoc A, et al. (2012) Role of TRPC3
channels in internal mammary artery. Arch Med Res 43: 431–437.
18. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, et al.
(1999) Direct activation of human TRPC6 and TRPC3 channels by
diacylglycerol. Nature 397(6716): 259–263.
19. Trebak M, Bird GS, McKay RR, Putney JW Jr (2002) Comparison of human
TRPC3 channels in receptor-activated and store-operated modes. Differential
sensitivity to channel blockers suggestsfundamental differences in channel
composition. J Biol Chem 277(24): 21617–21623.
20. Dietrich A, Mederos Y, Schnitzler M, Gollasch M, Gross V, et al. (2005)
Increased vascular smooth muscle contractility in TRPC62/2 mice. Mol Cell
Biol 25(16): 6980–6989.
21. Liu DY, Scholze A, Kreutz R, Markus Wehland-von-Trebra, Zidek W, et al.
(2007) Monocytes from spontaneously hypertensive rats show increased store-
operated and second messenger-operated calcium influx mediated by transient
receptor potential canonical type 3 channels. Am J Hypertens 20(10): 1111–
1118.
22. Liu Y, Thilo F, Kreutz R, Schulz A, Wendt N, et al. (2010) Tissue expression of
TRPC3 and TRPC6 in hypertensive munichwistarfro¨mter rats showing
proteinuria. Am J Nephrol 31(1): 36–44.
23. Thilo F, Baumunk D, Krause H, Schrader M, Miller K, et al. (2009) Transient
receptor potential canonical type 3 channels and blood pressure in humans.
J Hypertens 27(6): 1217–1223.
24. Zhao Z, Ni Y, Chen J, Zhong J, Yu H, et al. (2012) Increased migration of
monocytes in essential hypertension is associated with increased transient
receptor potential channel canonical type 3 channels. PLoS One 7(3): e32628.
25. Liu CL, Huang Y, Ngai CY, Leung YK, Yao XQ (2006) TRPC3 is involved in
flow- and bradykinin-induced vasodilation in rat small mesenteric arteries. Acta
Pharmacol Sin 27(8): 981–990.
26. Kochukov MY, Balasubramanian A, Noel RC, Marrell SP (2013) Role of
TRPC1 and TRPC3 channels in contraction and relaxation of mouse thoracic
aorta. J Vasc Res 50: 11–20.
27. Hartmann J, Dragicevic E, Adelsberger H, Henning HA, Sumser M, et al.
(2008) TRPC3 channels are required for synaptic transmission and motor
coordination. Neuron 59: 392–398.
28. Kim EC, Ahn DS, Yeon SI, Lim M, Lee YH (2012) Epithelial Na+ channel
proteins are mechanotransducers of myogenic constriction in rat posterior
cerebral arteries. Exp Physiol 947.4: 544–555.
29. Lim M, Choi SK, Cho YE, Yeon SI, Kim EC, et al. (2012) The role of
sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of
posterior cerebral arteries. PLoS One 7(4): e35177.
30. Yeon DS, Kim JS, Ahn DS, Kwon SH, Kang BS, et al. (2001) Role of protein
kinase C- or Rho A- induced Ca2+ sensitization in stretch-induced myogenic
tone. Cardiovasc Res 53: 431–438.
31. Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, et al. (2006) Classical
transient receptor potential channel 6 (TRPC6) is essential for hypoxic
pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci
103(50): 19093–19098.
32. Brayden JE, Earley S, Nelson MT, Readung S (2008) Transient receptor
potential (TRP) channels, vascular tone and autoregulation of cerebral blood
flow. Clin Exp Pharmacol Physiol 35(9): 1116–1120.
33. Peppiatt-Wildman CM, Albert AP, Saleh SN, Large WA (2007) Endothelin-1
activates a Ca2+-permeable cation channel with TRPC3 and TRPC7 properties
in rabbit coronary artery myocytes. J Physiol 580(3): 755–764.
34. Nishida M, Sumita M, Kitajima N (2013) Function and role of transient receptor
potential channels. Clin Calcium23(4): 561–568.
35. Clapham DE, Runnels LW, Stru¨bing C (2001) The TRP ion channel family.
Nat Rev Neurosci 2: 387–396.
36. Earley S, Waldron BJ, Brayden JE (2004) Critical role for transient receptor
potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ
Res 95(9): 922–929.
37. Welsh DG, Morielli AD, Nelson MT, Brayden JE (2002) Transient receptor
potential channels regulate myogenic tone of resistance arteries. Circ Res 90(3):
248–250.
38. Zhang DX, Gutterman DD (2011) Transient receptor potential channel
activation and endothelium-dependent dilation in the systemic circulation.
J Cardiovasc Pharmacol 57(2): 133–139.
39. Dietrich A, Gudermann T (2011) TRP channels in the cardiopulmonary
vasculature. Adv Exp Med Biol 704: 781–810.
40. Schiffrin EL (2004) Vascular stiffening and arterial compliance: Implications for
systolic blood pressure. Am J Hypertens 17(12.2): 39S–48S.
41. Senadheera S, Kim Y, Grayson H, Toemoe S, Kochukov MY, et al. (2012)
Transient receptor potential canonical type 3 channels facilitate endothelium-
derived hyperpolarization-mediated resistance artery vasodilator activity.
Cardiovasc Res 95: 439–447.
42. Tiruppathi C, Minshall RD, Paria BC, Vogel SM, Malik AB (2002). Role of
Ca2+ signaling in the regulation of endothelial permeability. Vasc Pharmacol 39:
173–185.
43. Schleifer H, Doleschal B, Lichtenegger M, Oppenrieder R, Derler I, et al. (2012)
Novel pyrazole compounds for pharmacological discrimination between
receptor-operated and store-operated Ca2+ entry pathways. Br J Pharmacol
167: 1712–1722.
TRPC3 Channels Control the Vascular Contractility
PLOS ONE | www.plosone.org 9 October 2014 | Volume 9 | Issue 10 | e110413
